“…12 In the cardiovascular literature, several studies have demonstrated that statin therapy improved neointimal coverage of drugeluting stents and also reduced rates of neointimal hyperplasia. 4,[13][14][15][16] In addition, statin use has also been shown to improve short-term mortality rates in patients receiving stent placement for acute coronary syndrome due to reductions in thrombotic complication rates. In a study of Ͼ1500 patients, Tentzeris et al 5 found that patients on high-dose statin therapy had lower odds of mortality at 3 months.…”